The combination of ICI and VEGF inhibitors together is based on the discovery that VEGF plays a role in immune suppression of the tumor microenvironment; hence, VEGF inhibition could provide a synergistic benefit with ICIs to reverse immune suppression and allow the immune system to more effectively destroy cancer cells [88,89,90]. Here, VEGFA is linked to neoplasm.